Shopping Cart 0
Cart Subtotal
AED 0

Global Pneumonia Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25543
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.

Scope of the Report:

This report focuses on the Pneumonia Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Pneumonia Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Pfizer Inc.

Glaxosmithkline Plc.

Merck & Co., Inc.

Sanofi Pasteur

Serum Institute of India Pvt. Ltd.

Johnson & Johnson

Astellas Pharma Inc.

Astrazeneca Plc.

CSL Limited

Emergent Biosolutions

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Pneumococcal Conjugate Vaccine (PCV13)

Pneumococcal Polysaccharide Vaccine (PPSV23)

Market Segment by Applications, can be divided into

Pneumonia

Meningitis

Sepsis

There are 15 Chapters to deeply display the global Pneumonia Vaccine market.

Chapter 1, to describe Pneumonia Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pneumonia Vaccine, with sales, revenue, and price of Pneumonia Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pneumonia Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Pneumonia Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Pneumonia Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Pneumonia Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Pneumococcal Conjugate Vaccine (PCV13)

1.2.2 Pneumococcal Polysaccharide Vaccine (PPSV23)

1.3 Market Analysis by Applications

1.3.1 Pneumonia

1.3.2 Meningitis

1.3.3 Sepsis

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer Inc.

2.1.1 Business Overview

2.1.2 Pneumonia Vaccine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Glaxosmithkline Plc.

2.2.1 Business Overview

2.2.2 Pneumonia Vaccine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Merck & Co., Inc.

2.3.1 Business Overview

2.3.2 Pneumonia Vaccine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sanofi Pasteur

2.4.1 Business Overview

2.4.2 Pneumonia Vaccine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Serum Institute of India Pvt. Ltd.

2.5.1 Business Overview

2.5.2 Pneumonia Vaccine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Johnson & Johnson

2.6.1 Business Overview

2.6.2 Pneumonia Vaccine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Astellas Pharma Inc.

2.7.1 Business Overview

2.7.2 Pneumonia Vaccine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Astrazeneca Plc.

2.8.1 Business Overview

2.8.2 Pneumonia Vaccine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 CSL Limited

2.9.1 Business Overview

2.9.2 Pneumonia Vaccine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 CSL Limited Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Emergent Biosolutions

2.10.1 Business Overview

2.10.2 Pneumonia Vaccine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Pneumonia Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Pneumonia Vaccine Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Pneumonia Vaccine Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Pneumonia Vaccine Manufacturer Market Share in 2017

3.3.2 Top 6 Pneumonia Vaccine Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Pneumonia Vaccine Market Analysis by Regions

4.1 Global Pneumonia Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Pneumonia Vaccine Sales and Market Share by Regions (2013-2018)

4.1.2 Global Pneumonia Vaccine Revenue and Market Share by Regions (2013-2018)

4.2 North America Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.3 Europe Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.5 South America Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)

5 North America Pneumonia Vaccine by Countries

5.1 North America Pneumonia Vaccine Sales, Revenue and Market Share by Countries

5.1.1 North America Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

5.1.2 North America Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

5.2 United States Pneumonia Vaccine Sales and Growth Rate (2013-2018)

5.3 Canada Pneumonia Vaccine Sales and Growth Rate (2013-2018)

5.4 Mexico Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6 Europe Pneumonia Vaccine by Countries

6.1 Europe Pneumonia Vaccine Sales, Revenue and Market Share by Countries

6.1.1 Europe Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

6.2 Germany Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.3 UK Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.4 France Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.5 Russia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.6 Italy Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7 Asia-Pacific Pneumonia Vaccine by Countries

7.1 Asia-Pacific Pneumonia Vaccine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

7.2 China Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.3 Japan Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.4 Korea Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.5 India Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

8 South America Pneumonia Vaccine by Countries

8.1 South America Pneumonia Vaccine Sales, Revenue and Market Share by Countries

8.1.1 South America Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

8.1.2 South America Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Pneumonia Vaccine Sales and Growth Rate (2013-2018)

8.3 Argentina Pneumonia Vaccine Sales and Growth Rate (2013-2018)

8.4 Colombia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9 Middle East and Africa Pneumonia Vaccine by Countries

9.1 Middle East and Africa Pneumonia Vaccine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.3 UAE Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.4 Egypt Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.5 Nigeria Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.6 South Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)

10 Global Pneumonia Vaccine Market Segment by Type

10.1 Global Pneumonia Vaccine Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Pneumonia Vaccine Sales and Market Share by Type (2013-2018)

10.1.2 Global Pneumonia Vaccine Revenue and Market Share by Type (2013-2018)

10.2 Pneumococcal Conjugate Vaccine (PCV13) Sales Growth and Price

10.2.1 Global Pneumococcal Conjugate Vaccine (PCV13) Sales Growth (2013-2018)

10.2.2 Global Pneumococcal Conjugate Vaccine (PCV13) Price (2013-2018)

10.3 Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth and Price

10.3.1 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth (2013-2018)

10.3.2 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Price (2013-2018)

11 Global Pneumonia Vaccine Market Segment by Application

11.1 Global Pneumonia Vaccine Sales Market Share by Application (2013-2018)

11.2 Pneumonia Sales Growth (2013-2018)

11.3 Meningitis Sales Growth (2013-2018)

11.4 Sepsis Sales Growth (2013-2018)

12 Pneumonia Vaccine Market Forecast (2018-2023)

12.1 Global Pneumonia Vaccine Sales, Revenue and Growth Rate (2018-2023)

12.2 Pneumonia Vaccine Market Forecast by Regions (2018-2023)

12.2.1 North America Pneumonia Vaccine Market Forecast (2018-2023)

12.2.2 Europe Pneumonia Vaccine Market Forecast (2018-2023)

12.2.3 Asia-Pacific Pneumonia Vaccine Market Forecast (2018-2023)

12.2.4 South America Pneumonia Vaccine Market Forecast (2018-2023)

12.2.5 Middle East and Africa Pneumonia Vaccine Market Forecast (2018-2023)

12.3 Pneumonia Vaccine Market Forecast by Type (2018-2023)

12.3.1 Global Pneumonia Vaccine Sales Forecast by Type (2018-2023)

12.3.2 Global Pneumonia Vaccine Market Share Forecast by Type (2018-2023)

12.4 Pneumonia Vaccine Market Forecast by Application (2018-2023)

12.4.1 Global Pneumonia Vaccine Sales Forecast by Application (2018-2023)

12.4.2 Global Pneumonia Vaccine Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Pneumonia Vaccine Picture

Table Product Specifications of Pneumonia Vaccine

Figure Global Sales Market Share of Pneumonia Vaccine by Types in 2017

Table Pneumonia Vaccine Types for Major Manufacturers

Figure Pneumococcal Conjugate Vaccine (PCV13) Picture

Figure Pneumococcal Polysaccharide Vaccine (PPSV23) Picture

Figure Pneumonia Vaccine Sales Market Share by Applications in 2017

Figure Pneumonia Picture

Figure Meningitis Picture

Figure Sepsis Picture

Figure United States Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure France Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure UK Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure China Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure India Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors

Table Pfizer Inc. Pneumonia Vaccine Type and Applications

Table Pfizer Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Glaxosmithkline Plc. Basic Information, Manufacturing Base and Competitors

Table Glaxosmithkline Plc. Pneumonia Vaccine Type and Applications

Table Glaxosmithkline Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors

Table Merck & Co., Inc. Pneumonia Vaccine Type and Applications

Table Merck & Co., Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors

Table Sanofi Pasteur Pneumonia Vaccine Type and Applications

Table Sanofi Pasteur Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors

Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Type and Applications

Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Pneumonia Vaccine Type and Applications

Table Johnson & Johnson Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors

Table Astellas Pharma Inc. Pneumonia Vaccine Type and Applications

Table Astellas Pharma Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Astrazeneca Plc. Basic Information, Manufacturing Base and Competitors

Table Astrazeneca Plc. Pneumonia Vaccine Type and Applications

Table Astrazeneca Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table CSL Limited Basic Information, Manufacturing Base and Competitors

Table CSL Limited Pneumonia Vaccine Type and Applications

Table CSL Limited Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Emergent Biosolutions Basic Information, Manufacturing Base and Competitors

Table Emergent Biosolutions Pneumonia Vaccine Type and Applications

Table Emergent Biosolutions Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Pneumonia Vaccine Sales by Manufacturer (2016-2017)

Figure Global Pneumonia Vaccine Sales Market Share by Manufacturer in 2016

Figure Global Pneumonia Vaccine Sales Market Share by Manufacturer in 2017

Table Global Pneumonia Vaccine Revenue by Manufacturer (2016-2017)

Figure Global Pneumonia Vaccine Revenue Market Share by Manufacturer in 2016

Figure Global Pneumonia Vaccine Revenue Market Share by Manufacturer in 2017

Figure Top 3 Pneumonia Vaccine Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Pneumonia Vaccine Manufacturer (Revenue) Market Share in 2017

Figure Global Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Global Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table Global Pneumonia Vaccine Sales by Regions (2013-2018)

Table Global Pneumonia Vaccine Sales Market Share by Regions (2013-2018)

Table Global Pneumonia Vaccine Revenue by Regions (2013-2018)

Figure Global Pneumonia Vaccine Revenue Market Share by Regions in 2013

Figure Global Pneumonia Vaccine Revenue Market Share by Regions in 2017

Figure North America Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Europe Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure South America Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure North America Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table North America Pneumonia Vaccine Sales by Countries (2013-2018)

Table North America Pneumonia Vaccine Sales Market Share by Countries (2013-2018)

Figure North America Pneumonia Vaccine Sales Market Share by Countries in 2013

Figure North America Pneumonia Vaccine Sales Market Share by Countries in 2017

Table North America Pneumonia Vaccine Revenue by Countries (2013-2018)

Table North America Pneumonia Vaccine Revenue Market Share by Countries (2013-2018)

Figure North America Pneumonia Vaccine Revenue Market Share by Countries in 2013

Figure North America Pneumonia Vaccine Revenue Market Share by Countries in 2017

Figure United States Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Canada Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Mexico Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Europe Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table Europe Pneumonia Vaccine Sales by Countries (2013-2018)

Table Europe Pneumonia Vaccine Sales Market Share by Countries (2013-2018)

Table Europe Pneumonia Vaccine Revenue by Countries (2013-2018)

Figure Europe Pneumonia Vaccine Revenue Market Share by Countries in 2016

Figure Europe Pneumonia Vaccine Revenue Market Share by Countries in 2017

Figure Germany Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure UK Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure France Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Russia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Italy Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Pneumonia Vaccine Sales by Countries (2013-2018)

Table Asia-Pacific Pneumonia Vaccine Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Pneumonia Vaccine Sales Market Share by Countries 2017

Table Asia-Pacific Pneumonia Vaccine Revenue by Countries (2013-2018)

Figure Asia-Pacific Pneumonia Vaccine Revenue Market Share by Countries 2017

Figure China Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Japan Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Korea Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure India Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Southeast Asia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure South America Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table South America Pneumonia Vaccine Sales by Countries (2013-2018)

Table South America Pneumonia Vaccine Sales Market Share by Countries (2013-2018)

Figure South America Pneumonia Vaccine Sales Market Share by Countries in 2017

Table South America Pneumonia Vaccine Revenue by Countries (2013-2018)

Table South America Pneumonia Vaccine Revenue Market Share by Countries (2013-2018)

Figure South America Pneumonia Vaccine Revenue Market Share by Countries in 2017

Figure Brazil Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Argentina Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Colombia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Pneumonia Vaccine Sales by Countries (2013-2018)

Table Middle East and Africa Pneumonia Vaccine Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Pneumonia Vaccine Sales Market Share by Countries in 2017

Table Middle East and Africa Pneumonia Vaccine Revenue by Countries (2013-2018)

Table Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries in 2013

Figure Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries in 2017

Figure Saudi Arabia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure UAE Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Egypt Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Nigeria Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure South Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Table Global Pneumonia Vaccine Sales by Type (2013-2018)

Table Global Pneumonia Vaccine Sales Share by Type (2013-2018)

Table Global Pneumonia Vaccine Revenue by Type (2013-2018)

Table Global Pneumonia Vaccine Revenue Share by Type (2013-2018)

Figure Global Pneumococcal Conjugate Vaccine (PCV13) Sales Growth (2013-2018)

Figure Global Pneumococcal Conjugate Vaccine (PCV13) Price (2013-2018)

Figure Global Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth (2013-2018)

Figure Global Pneumococcal Polysaccharide Vaccine (PPSV23) Price (2013-2018)

Table Global Pneumonia Vaccine Sales by Application (2013-2018)

Table Global Pneumonia Vaccine Sales Share by Application (2013-2018)

Figure Global Meningitis Sales Growth (2013-2018)

Figure Global Sepsis Sales Growth (2013-2018)

Figure Global Pneumonia Vaccine Sales, Revenue and Growth Rate (2018-2023)

Table Global Pneumonia Vaccine Sales Forecast by Regions (2018-2023)

Table Global Pneumonia Vaccine Market Share Forecast by Regions (2018-2023)

Figure North America Sales Pneumonia Vaccine Market Forecast (2018-2023)

Figure Europe Sales Pneumonia Vaccine Market Forecast (2018-2023)

Figure Asia-Pacific Sales Pneumonia Vaccine Market Forecast (2018-2023)

Figure South America Sales Pneumonia Vaccine Market Forecast (2018-2023)

Figure Middle East and Africa Sales Pneumonia Vaccine Market Forecast (2018-2023)

Table Global Pneumonia Vaccine Sales Forecast by Type (2018-2023)

Table Global Pneumonia Vaccine Market Share Forecast by Type (2018-2023)

Table Global Pneumonia Vaccine Sales Forecast by Application (2018-2023)

Table Global Pneumonia Vaccine Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Pfizer Inc.

Glaxosmithkline Plc.

Merck & Co., Inc.

Sanofi Pasteur

Serum Institute of India Pvt. Ltd.

Johnson & Johnson

Astellas Pharma Inc.

Astrazeneca Plc.

CSL Limited

Emergent Biosolutions

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.

Scope of the Report:

This report focuses on the Pneumonia Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Pneumonia Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Pfizer Inc.

Glaxosmithkline Plc.

Merck & Co., Inc.

Sanofi Pasteur

Serum Institute of India Pvt. Ltd.

Johnson & Johnson

Astellas Pharma Inc.

Astrazeneca Plc.

CSL Limited

Emergent Biosolutions

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Pneumococcal Conjugate Vaccine (PCV13)

Pneumococcal Polysaccharide Vaccine (PPSV23)

Market Segment by Applications, can be divided into

Pneumonia

Meningitis

Sepsis

There are 15 Chapters to deeply display the global Pneumonia Vaccine market.

Chapter 1, to describe Pneumonia Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pneumonia Vaccine, with sales, revenue, and price of Pneumonia Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pneumonia Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Pneumonia Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Pneumonia Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Pneumonia Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Pneumococcal Conjugate Vaccine (PCV13)

1.2.2 Pneumococcal Polysaccharide Vaccine (PPSV23)

1.3 Market Analysis by Applications

1.3.1 Pneumonia

1.3.2 Meningitis

1.3.3 Sepsis

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer Inc.

2.1.1 Business Overview

2.1.2 Pneumonia Vaccine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Glaxosmithkline Plc.

2.2.1 Business Overview

2.2.2 Pneumonia Vaccine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Merck & Co., Inc.

2.3.1 Business Overview

2.3.2 Pneumonia Vaccine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sanofi Pasteur

2.4.1 Business Overview

2.4.2 Pneumonia Vaccine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Serum Institute of India Pvt. Ltd.

2.5.1 Business Overview

2.5.2 Pneumonia Vaccine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Johnson & Johnson

2.6.1 Business Overview

2.6.2 Pneumonia Vaccine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Astellas Pharma Inc.

2.7.1 Business Overview

2.7.2 Pneumonia Vaccine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Astrazeneca Plc.

2.8.1 Business Overview

2.8.2 Pneumonia Vaccine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 CSL Limited

2.9.1 Business Overview

2.9.2 Pneumonia Vaccine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 CSL Limited Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Emergent Biosolutions

2.10.1 Business Overview

2.10.2 Pneumonia Vaccine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Pneumonia Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Pneumonia Vaccine Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Pneumonia Vaccine Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Pneumonia Vaccine Manufacturer Market Share in 2017

3.3.2 Top 6 Pneumonia Vaccine Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Pneumonia Vaccine Market Analysis by Regions

4.1 Global Pneumonia Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Pneumonia Vaccine Sales and Market Share by Regions (2013-2018)

4.1.2 Global Pneumonia Vaccine Revenue and Market Share by Regions (2013-2018)

4.2 North America Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.3 Europe Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.5 South America Pneumonia Vaccine Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)

5 North America Pneumonia Vaccine by Countries

5.1 North America Pneumonia Vaccine Sales, Revenue and Market Share by Countries

5.1.1 North America Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

5.1.2 North America Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

5.2 United States Pneumonia Vaccine Sales and Growth Rate (2013-2018)

5.3 Canada Pneumonia Vaccine Sales and Growth Rate (2013-2018)

5.4 Mexico Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6 Europe Pneumonia Vaccine by Countries

6.1 Europe Pneumonia Vaccine Sales, Revenue and Market Share by Countries

6.1.1 Europe Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

6.2 Germany Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.3 UK Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.4 France Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.5 Russia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

6.6 Italy Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7 Asia-Pacific Pneumonia Vaccine by Countries

7.1 Asia-Pacific Pneumonia Vaccine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

7.2 China Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.3 Japan Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.4 Korea Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.5 India Pneumonia Vaccine Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

8 South America Pneumonia Vaccine by Countries

8.1 South America Pneumonia Vaccine Sales, Revenue and Market Share by Countries

8.1.1 South America Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

8.1.2 South America Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Pneumonia Vaccine Sales and Growth Rate (2013-2018)

8.3 Argentina Pneumonia Vaccine Sales and Growth Rate (2013-2018)

8.4 Colombia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9 Middle East and Africa Pneumonia Vaccine by Countries

9.1 Middle East and Africa Pneumonia Vaccine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.3 UAE Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.4 Egypt Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.5 Nigeria Pneumonia Vaccine Sales and Growth Rate (2013-2018)

9.6 South Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)

10 Global Pneumonia Vaccine Market Segment by Type

10.1 Global Pneumonia Vaccine Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Pneumonia Vaccine Sales and Market Share by Type (2013-2018)

10.1.2 Global Pneumonia Vaccine Revenue and Market Share by Type (2013-2018)

10.2 Pneumococcal Conjugate Vaccine (PCV13) Sales Growth and Price

10.2.1 Global Pneumococcal Conjugate Vaccine (PCV13) Sales Growth (2013-2018)

10.2.2 Global Pneumococcal Conjugate Vaccine (PCV13) Price (2013-2018)

10.3 Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth and Price

10.3.1 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth (2013-2018)

10.3.2 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Price (2013-2018)

11 Global Pneumonia Vaccine Market Segment by Application

11.1 Global Pneumonia Vaccine Sales Market Share by Application (2013-2018)

11.2 Pneumonia Sales Growth (2013-2018)

11.3 Meningitis Sales Growth (2013-2018)

11.4 Sepsis Sales Growth (2013-2018)

12 Pneumonia Vaccine Market Forecast (2018-2023)

12.1 Global Pneumonia Vaccine Sales, Revenue and Growth Rate (2018-2023)

12.2 Pneumonia Vaccine Market Forecast by Regions (2018-2023)

12.2.1 North America Pneumonia Vaccine Market Forecast (2018-2023)

12.2.2 Europe Pneumonia Vaccine Market Forecast (2018-2023)

12.2.3 Asia-Pacific Pneumonia Vaccine Market Forecast (2018-2023)

12.2.4 South America Pneumonia Vaccine Market Forecast (2018-2023)

12.2.5 Middle East and Africa Pneumonia Vaccine Market Forecast (2018-2023)

12.3 Pneumonia Vaccine Market Forecast by Type (2018-2023)

12.3.1 Global Pneumonia Vaccine Sales Forecast by Type (2018-2023)

12.3.2 Global Pneumonia Vaccine Market Share Forecast by Type (2018-2023)

12.4 Pneumonia Vaccine Market Forecast by Application (2018-2023)

12.4.1 Global Pneumonia Vaccine Sales Forecast by Application (2018-2023)

12.4.2 Global Pneumonia Vaccine Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Pneumonia Vaccine Picture

Table Product Specifications of Pneumonia Vaccine

Figure Global Sales Market Share of Pneumonia Vaccine by Types in 2017

Table Pneumonia Vaccine Types for Major Manufacturers

Figure Pneumococcal Conjugate Vaccine (PCV13) Picture

Figure Pneumococcal Polysaccharide Vaccine (PPSV23) Picture

Figure Pneumonia Vaccine Sales Market Share by Applications in 2017

Figure Pneumonia Picture

Figure Meningitis Picture

Figure Sepsis Picture

Figure United States Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure France Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure UK Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure China Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure India Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)

Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors

Table Pfizer Inc. Pneumonia Vaccine Type and Applications

Table Pfizer Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Glaxosmithkline Plc. Basic Information, Manufacturing Base and Competitors

Table Glaxosmithkline Plc. Pneumonia Vaccine Type and Applications

Table Glaxosmithkline Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors

Table Merck & Co., Inc. Pneumonia Vaccine Type and Applications

Table Merck & Co., Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors

Table Sanofi Pasteur Pneumonia Vaccine Type and Applications

Table Sanofi Pasteur Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors

Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Type and Applications

Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Pneumonia Vaccine Type and Applications

Table Johnson & Johnson Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors

Table Astellas Pharma Inc. Pneumonia Vaccine Type and Applications

Table Astellas Pharma Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Astrazeneca Plc. Basic Information, Manufacturing Base and Competitors

Table Astrazeneca Plc. Pneumonia Vaccine Type and Applications

Table Astrazeneca Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table CSL Limited Basic Information, Manufacturing Base and Competitors

Table CSL Limited Pneumonia Vaccine Type and Applications

Table CSL Limited Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Emergent Biosolutions Basic Information, Manufacturing Base and Competitors

Table Emergent Biosolutions Pneumonia Vaccine Type and Applications

Table Emergent Biosolutions Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Pneumonia Vaccine Sales by Manufacturer (2016-2017)

Figure Global Pneumonia Vaccine Sales Market Share by Manufacturer in 2016

Figure Global Pneumonia Vaccine Sales Market Share by Manufacturer in 2017

Table Global Pneumonia Vaccine Revenue by Manufacturer (2016-2017)

Figure Global Pneumonia Vaccine Revenue Market Share by Manufacturer in 2016

Figure Global Pneumonia Vaccine Revenue Market Share by Manufacturer in 2017

Figure Top 3 Pneumonia Vaccine Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Pneumonia Vaccine Manufacturer (Revenue) Market Share in 2017

Figure Global Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Global Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table Global Pneumonia Vaccine Sales by Regions (2013-2018)

Table Global Pneumonia Vaccine Sales Market Share by Regions (2013-2018)

Table Global Pneumonia Vaccine Revenue by Regions (2013-2018)

Figure Global Pneumonia Vaccine Revenue Market Share by Regions in 2013

Figure Global Pneumonia Vaccine Revenue Market Share by Regions in 2017

Figure North America Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Europe Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure South America Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure North America Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table North America Pneumonia Vaccine Sales by Countries (2013-2018)

Table North America Pneumonia Vaccine Sales Market Share by Countries (2013-2018)

Figure North America Pneumonia Vaccine Sales Market Share by Countries in 2013

Figure North America Pneumonia Vaccine Sales Market Share by Countries in 2017

Table North America Pneumonia Vaccine Revenue by Countries (2013-2018)

Table North America Pneumonia Vaccine Revenue Market Share by Countries (2013-2018)

Figure North America Pneumonia Vaccine Revenue Market Share by Countries in 2013

Figure North America Pneumonia Vaccine Revenue Market Share by Countries in 2017

Figure United States Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Canada Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Mexico Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Europe Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table Europe Pneumonia Vaccine Sales by Countries (2013-2018)

Table Europe Pneumonia Vaccine Sales Market Share by Countries (2013-2018)

Table Europe Pneumonia Vaccine Revenue by Countries (2013-2018)

Figure Europe Pneumonia Vaccine Revenue Market Share by Countries in 2016

Figure Europe Pneumonia Vaccine Revenue Market Share by Countries in 2017

Figure Germany Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure UK Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure France Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Russia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Italy Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Pneumonia Vaccine Sales by Countries (2013-2018)

Table Asia-Pacific Pneumonia Vaccine Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Pneumonia Vaccine Sales Market Share by Countries 2017

Table Asia-Pacific Pneumonia Vaccine Revenue by Countries (2013-2018)

Figure Asia-Pacific Pneumonia Vaccine Revenue Market Share by Countries 2017

Figure China Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Japan Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Korea Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure India Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Southeast Asia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure South America Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table South America Pneumonia Vaccine Sales by Countries (2013-2018)

Table South America Pneumonia Vaccine Sales Market Share by Countries (2013-2018)

Figure South America Pneumonia Vaccine Sales Market Share by Countries in 2017

Table South America Pneumonia Vaccine Revenue by Countries (2013-2018)

Table South America Pneumonia Vaccine Revenue Market Share by Countries (2013-2018)

Figure South America Pneumonia Vaccine Revenue Market Share by Countries in 2017

Figure Brazil Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Argentina Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Colombia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Pneumonia Vaccine Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Pneumonia Vaccine Sales by Countries (2013-2018)

Table Middle East and Africa Pneumonia Vaccine Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Pneumonia Vaccine Sales Market Share by Countries in 2017

Table Middle East and Africa Pneumonia Vaccine Revenue by Countries (2013-2018)

Table Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries in 2013

Figure Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries in 2017

Figure Saudi Arabia Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure UAE Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Egypt Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure Nigeria Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Figure South Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)

Table Global Pneumonia Vaccine Sales by Type (2013-2018)

Table Global Pneumonia Vaccine Sales Share by Type (2013-2018)

Table Global Pneumonia Vaccine Revenue by Type (2013-2018)

Table Global Pneumonia Vaccine Revenue Share by Type (2013-2018)

Figure Global Pneumococcal Conjugate Vaccine (PCV13) Sales Growth (2013-2018)

Figure Global Pneumococcal Conjugate Vaccine (PCV13) Price (2013-2018)

Figure Global Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth (2013-2018)

Figure Global Pneumococcal Polysaccharide Vaccine (PPSV23) Price (2013-2018)

Table Global Pneumonia Vaccine Sales by Application (2013-2018)

Table Global Pneumonia Vaccine Sales Share by Application (2013-2018)

Figure Global Meningitis Sales Growth (2013-2018)

Figure Global Sepsis Sales Growth (2013-2018)

Figure Global Pneumonia Vaccine Sales, Revenue and Growth Rate (2018-2023)

Table Global Pneumonia Vaccine Sales Forecast by Regions (2018-2023)

Table Global Pneumonia Vaccine Market Share Forecast by Regions (2018-2023)

Figure North America Sales Pneumonia Vaccine Market Forecast (2018-2023)

Figure Europe Sales Pneumonia Vaccine Market Forecast (2018-2023)

Figure Asia-Pacific Sales Pneumonia Vaccine Market Forecast (2018-2023)

Figure South America Sales Pneumonia Vaccine Market Forecast (2018-2023)

Figure Middle East and Africa Sales Pneumonia Vaccine Market Forecast (2018-2023)

Table Global Pneumonia Vaccine Sales Forecast by Type (2018-2023)

Table Global Pneumonia Vaccine Market Share Forecast by Type (2018-2023)

Table Global Pneumonia Vaccine Sales Forecast by Application (2018-2023)

Table Global Pneumonia Vaccine Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Pfizer Inc.

Glaxosmithkline Plc.

Merck & Co., Inc.

Sanofi Pasteur

Serum Institute of India Pvt. Ltd.

Johnson & Johnson

Astellas Pharma Inc.

Astrazeneca Plc.

CSL Limited

Emergent Biosolutions